Carbidopa/Levodopa Archives

With Positive Phase II Results, Cerevance Proves Concept in Parkinson’s

Brain Diseases, Clinical Trials, CNS Disorders, Drug Discovery, First-In-Class, Genetic Data, Levodopa, Parkinson’s disease, R&D

Private drug discovery company Cerevance reported positive clinical trial results for CVN424, an experimental treatment for Parkinson’s disease.

FDA approves new add-on drug for Parkinson’s

Adenosine A2A Receptor Antagonists, Approvals, Carbidopa/Levodopa, FDA, FDA/Regulatory, OFF Episodes, Parkinson's Disease

The U.S. FDA approved Kyowa Kirin’s Nourianz (istradefylline) as an add-on treatment to levodopa/carbidopa in adults with Parkinson’s disease who experience “off” episodes.

Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms

Catechol-O-Methyltransferase (COMT) Inhibitors, Clinical Trials, Levodopa, Parkinson’s disease, R&D

San Diego-based Neurocrine Biosciences presented data from two Phase III clinical trials of opicapone, a once-daily, oral catechol-O-methyltransferase (COMT) inhibitor for Parkinson’s disease.